Fritextsökning
Artiklar per år
Innehållstyper
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? At the seminar Patent Strategies in the Biotech Company, you will have the chance to find out why this might not be the best idea.
-
Hey Klementina Österberg ...
... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into the research of analyzing markers in body fluids.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and attractions. Whatever your interest might be: history, art, music or design, you can find it here!
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
Martin Willner, Manager Lab, Nordic Service Manager, Mettler-Toledo AB
Why are you going to Scanlab+Biotech Forum?
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Young, bright and committed to labtech
, becoming the new CEO of Swedish Labtech.
-
With their hands on the legal levers
It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is focus according to Yvonne Mårtensson.
-
Euris avnoteras
Styrelsen har beslutat att lista om bolaget på en annan handelsplats, för att minska kraven på administration.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
BREAKING